1. Home
  2. OCCI vs IMRX Comparison

OCCI vs IMRX Comparison

Compare OCCI & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCCI
  • IMRX
  • Stock Information
  • Founded
  • OCCI N/A
  • IMRX 2008
  • Country
  • OCCI United States
  • IMRX United States
  • Employees
  • OCCI N/A
  • IMRX N/A
  • Industry
  • OCCI Trusts Except Educational Religious and Charitable
  • IMRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • OCCI Finance
  • IMRX Health Care
  • Exchange
  • OCCI Nasdaq
  • IMRX Nasdaq
  • Market Cap
  • OCCI 160.5M
  • IMRX 145.7M
  • IPO Year
  • OCCI N/A
  • IMRX 2021
  • Fundamental
  • Price
  • OCCI $6.25
  • IMRX $4.18
  • Analyst Decision
  • OCCI
  • IMRX Strong Buy
  • Analyst Count
  • OCCI 0
  • IMRX 4
  • Target Price
  • OCCI N/A
  • IMRX $13.25
  • AVG Volume (30 Days)
  • OCCI 115.8K
  • IMRX 3.2M
  • Earning Date
  • OCCI 12-11-2023
  • IMRX 08-05-2025
  • Dividend Yield
  • OCCI 24.32%
  • IMRX N/A
  • EPS Growth
  • OCCI N/A
  • IMRX N/A
  • EPS
  • OCCI N/A
  • IMRX N/A
  • Revenue
  • OCCI N/A
  • IMRX N/A
  • Revenue This Year
  • OCCI N/A
  • IMRX N/A
  • Revenue Next Year
  • OCCI $10.19
  • IMRX N/A
  • P/E Ratio
  • OCCI N/A
  • IMRX N/A
  • Revenue Growth
  • OCCI N/A
  • IMRX N/A
  • 52 Week Low
  • OCCI $5.47
  • IMRX $1.00
  • 52 Week High
  • OCCI $10.15
  • IMRX $4.60
  • Technical
  • Relative Strength Index (RSI)
  • OCCI 51.26
  • IMRX 68.29
  • Support Level
  • OCCI $6.21
  • IMRX $3.95
  • Resistance Level
  • OCCI $6.30
  • IMRX $4.55
  • Average True Range (ATR)
  • OCCI 0.07
  • IMRX 0.42
  • MACD
  • OCCI 0.02
  • IMRX 0.04
  • Stochastic Oscillator
  • OCCI 82.76
  • IMRX 75.72

About OCCI OFS Credit Company Inc.

OFS Credit Co Inc is a non-diversified, closed-end management investment company. Its investment objective is to generate current income, with a secondary objective to generate capital appreciation primarily through investment in collateralized loan obligation (CLO) equity and debt securities. The company invests in floating rate credit instruments and other structured credit investments, including; collateralized loan obligation (CLO) debt and subordinated (i.e., residual or equity) securities; traditional corporate credit investments, including leveraged loans and high yield bonds; opportunistic credit investments, including stressed and distressed credit situations and long/short credit investments; and other credit-related instruments.

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

Share on Social Networks: